Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Royalty or License | $259,000 | 5 | 96.3% |
| Consulting Fee | $6,356 | 3 | 2.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,945 | 1 | 0.7% |
| Travel and Lodging | $1,484 | 6 | 0.6% |
| Food and Beverage | $218.72 | 6 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Research & Development, LLC | $259,000 | 5 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $5,146 | 5 | $0 (2021) |
| Regeneron Pharmaceuticals, Inc. | $4,858 | 11 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $44,000 | 1 | Janssen Research & Development, LLC ($44,000) |
| 2022 | $66,000 | 3 | Janssen Research & Development, LLC ($66,000) |
| 2021 | $151,148 | 2 | Janssen Research & Development, LLC ($149,000) |
| 2020 | $389.00 | 1 | AstraZeneca Pharmaceuticals LP ($389.00) |
| 2019 | $2,609 | 3 | AstraZeneca Pharmaceuticals LP ($2,609) |
| 2017 | $4,858 | 11 | Regeneron Pharmaceuticals, Inc. ($4,858) |
All Payment Transactions
21 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/17/2023 | Janssen Research & Development, LLC | — | Royalty or License | Cash or cash equivalent | $44,000.00 | General |
| 11/07/2022 | Janssen Research & Development, LLC | — | Royalty or License | Cash or cash equivalent | $14,000.00 | General |
| 04/04/2022 | Janssen Research & Development, LLC | — | Royalty or License | Cash or cash equivalent | $12,000.00 | General |
| 02/07/2022 | Janssen Research & Development, LLC | — | Royalty or License | Cash or cash equivalent | $40,000.00 | General |
| 08/03/2021 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $2,148.00 | General |
| 07/23/2021 | Janssen Research & Development, LLC | — | Royalty or License | Cash or cash equivalent | $149,000.00 | General |
| 12/17/2020 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $389.00 | General |
| 12/24/2019 | AstraZeneca Pharmaceuticals LP | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,945.00 | General |
| 12/24/2019 | AstraZeneca Pharmaceuticals LP | — | Travel and Lodging | Cash or cash equivalent | $655.48 | General |
| 12/24/2019 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | Cash or cash equivalent | $8.11 | General |
| 06/14/2017 | Regeneron Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $3,819.00 | General |
| 06/14/2017 | Regeneron Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $18.00 | General |
| 06/14/2017 | Regeneron Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $10.54 | General |
| 03/23/2017 | Regeneron Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $185.95 | General |
| 03/23/2017 | Regeneron Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $76.95 | General |
| 03/23/2017 | Regeneron Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $54.00 | General |
| 03/23/2017 | Regeneron Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $35.37 | General |
| 03/23/2017 | Regeneron Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $33.75 | General |
| 02/27/2017 | Regeneron Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $109.38 | General |
| 02/01/2017 | Regeneron Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $492.93 | General |
| 02/01/2017 | Regeneron Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $22.00 | General |
About Dr. James Gern, MD
Dr. James Gern, MD is a Pediatric Allergy/Immunology healthcare provider based in Madison, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1154399038.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Gern, MD has received a total of $269,003 in payments from pharmaceutical and medical device companies, with $44,000 received in 2023. These payments were reported across 21 transactions from 3 companies. The most common payment nature is "Royalty or License" ($259,000).
Practice Information
- Specialty Pediatric Allergy/Immunology
- Location Madison, WI
- Active Since 03/08/2006
- Last Updated 01/11/2021
- Taxonomy Code 2080P0201X
- Entity Type Individual
- NPI Number 1154399038
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Allergy/Immunology Doctors in Madison
Sameer Mathur, Md Phd, MD PHD
Pediatric Allergy/Immunology — Payments: $299,444
Dr. Daniel Jackson, M.d, M.D
Pediatric Allergy/Immunology — Payments: $187,340
Mark Moss, Md, MD
Pediatric Allergy/Immunology — Payments: $93,464
Robert Lemanske, Md, MD
Pediatric Allergy/Immunology — Payments: $18,402
Anne Marie Singh, M.d, M.D
Pediatric Allergy/Immunology — Payments: $12,720
Sima Ramratnam, M.d, M.D
Pediatric Allergy/Immunology — Payments: $4,714